期刊文献+

舍他康唑对于耐药假丝酵母菌药物敏感性研究 被引量:2

Effects of sertaconazole on drug-resistant Candida species
原文传递
导出
摘要 目的研究耐药真菌对抗真菌药物舍他康唑的药物敏感情况。方法 2015年6-8月于北京大学第一医院,参照美国临床实验室标准化协会(National Committee for Clinical Laboratory Standards,CLSI)推荐的M27-A3方案的微量液基稀释法,测量舍他康唑、伊曲康唑、咪康唑、克霉唑和氟康唑5种抗真菌药物对临床分离的120株耐药白假丝酵母菌、120株耐药光滑假丝酵母菌、30株敏感白假丝酵母菌株的最低抑菌浓度(MIC)。结果 (1)舍他康唑对白假丝酵母菌各耐药组的MIC值均高于非耐药组。(2)舍他康唑对光滑假丝酵母菌各耐药组的抗菌效果优于白假丝酵母菌组。结论舍他康唑在临床上治疗耐药光滑假丝酵母菌有一定的应用前景。 Objective To research the drug susceptibility differences of Sertaconazole against drug-resistant Candida spices. Methods Susceptibility testing of 120 drug-resistant Candida albicans, 120 Candida glabrata and 30 suscepti- ble Candida albieans were performed using the broth microdilution method (National Committee for Clinical Laboratory Standards, CLSI) between June and August of 2015 in Peking University First Hospital. Results (1) The minimal inhibi- tory concentrations (MICs) of sertaconazole against drug-resistant Candida albicans groups were higher compared with the susceptive group. (2) MICs of sertaconazole against drug-resistant Candida albicans groups were higher than the drug-resistant Candida glabrata ones.Conclusion Sertaeonazole may be used to treat drug-resistant Candida glabrata.
出处 《中国实用妇科与产科杂志》 CAS CSCD 北大核心 2016年第4期353-356,共4页 Chinese Journal of Practical Gynecology and Obstetrics
关键词 舍他康唑 耐药假丝酵母菌 最低抑菌浓度 Sertaconazole drug-resistant Candida spices minimal inhibitory concentrations
  • 相关文献

参考文献10

  • 1Ono F,Yasumoto S.Genital candidiasis[J].Nippon Rinsho, 2009, 67(1):157-161.
  • 2刘朝晖,王晓莉,廖秦平.复发性外阴阴道假丝酵母菌病的菌群分析与治疗[J].实用妇产科杂志,2009,25(12):730-732. 被引量:22
  • 3刘朝晖,廖秦平.北京8家医院外阴阴道假丝酵母菌病致病菌种分析[J].北京医学,2011,33(3):210-212. 被引量:5
  • 4Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of yeasts : ap- proved standard [EB/OL] [2015- 08- 27]. http://www.clsi.org/ source/orde-rs/free/M27-A3, pdf.
  • 5Published 2008. Sobel JD. Vulvovaginal candidosis [J]. Lancet, 2007, 369 (9577): 1961-1971.
  • 6Achkar JM, Fries BC. Candida infections of the genitourinary tract [J]. Clin Mierobiol Rev, 2010,23(2): 253-273.
  • 7Workowski KA, Berman S, Centers for Disease Control and Pre- vention ( CDC ) . Sexually transmitted diseases treatment guide- lines, 2010[J]. MMWR Recomm Rep, 2010,59(RR-12):1-110.
  • 8Croxtall JD,Plesker GL.Sertaeonazole: a review of its use in the management of superficial mycoses in dermatology and gynaeco- logy[J].Dmgs,2009,69(3):339-359.
  • 9PfallerMA,SuttonDA. Review of in vitro activity of sertaconazole nitrate in the treatment of superficial fungal infections[J]. Diagn Mierobiol Infect Dis, 2006, 56(2): 147-152.
  • 10CarrilIo-Mufloz AJ, Giusiano G,Ezkurra PA, et al.Sertacon- azole:updated review of a topical antifungal agent[J].Expert Rev Anti Infect Ther,2005,3(3):333-342.

二级参考文献12

共引文献23

同被引文献12

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部